EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Long-Term Outcomes of Tachycardia-Induced Cardiomyopathy Compared with Idiopathic Dilated Cardiomyopathy

Moshe Katz, Amit Meitus, Michael Arad, Anthony Aizer, Eyal Nof, Roy Beinart iD

Journal of Clinical Medicine · 10.02.2023 · 12 (4) · 1412

DOI: 10.3390/jcm12041412 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 10.02.2023. Verfasst von Moshe Katz und 5 weiteren Autor:innen. Beteiligte Einrichtung: Sheba Medical Center, Ramat Gan 5266202, Israel. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background: data on the natural course and prognosis of tachycardia-induced cardiomyopathy (TICMP) and comparison with idiopathic dilated cardiomyopathies (IDCM) are scarce. Objective: To compare the clinical presentation, comorbidities, and long-term outcomes of TICMP patients with IDCM patients. Methods: a retrospective cohort study of patients hospitalized with new-onset TICMP or IDCM. The primary endpoint was a composite of death, myocardial infarction, thromboembolic events, assist device, heart transplantation, and ventricular tachycardia or fibrillation (VT/VF). The secondary endpoint was recurrent hospitalization due to heart failure (HF) exacerbation. Results: the cohort was comprised of 64 TICMP and 66 IDCM patients. The primary composite endpoint and all-cause mortality were similar between the groups during a median follow-up of ~6 years (36% versus 29%, p = 0.33 and 22% versus 15%, p = 0.15, respectively). Survival analysis showed no significant difference between TICMP and IDCM groups for the composite endpoint (p = 0.75), all-cause mortality (p = 0.65), and hospitalizations due to heart failure exacerbation. Nonetheless, the incidence of recurrent hospitalization was significantly higher in TICMP patients (incidence rate ratio 1.59; p = 0.009). Conclusions: patients with TICMP have similar long-term outcomes as those with IDCM. However, it portends a higher rate of HF readmissions, mostly due to arrhythmia recurrences.

Schlagwörter

Stichwörter der Autor:innen

arrhythmiaatrial fibrillationcardiomyopathyheart failurepremature ventricular beats

Autor:innen und Institutionen

  • Sheba Medical Center, Ramat Gan 5266202, Israel.
  • Sackler School of Medicine, Tel-Aviv University, Tel Aviv 6997801, Israel.
  • NYU Grossman School of Medicine, New York, NY 10016, USA.

ORCID-Profile: Roy Beinart

Zitieren

APA

Katz, M., Meitus, A., Arad, M., Aizer, A., Nof, E., & Beinart, R. (2023). Long-Term Outcomes of Tachycardia-Induced Cardiomyopathy Compared with Idiopathic Dilated Cardiomyopathy. Journal of Clinical Medicine, 12(4), 1412. https://doi.org/10.3390/jcm12041412

Vancouver

Katz M, Meitus A, Arad M, Aizer A, Nof E, Beinart R. Long-Term Outcomes of Tachycardia-Induced Cardiomyopathy Compared with Idiopathic Dilated Cardiomyopathy. Journal of Clinical Medicine. 2023;12(4):1412. doi:10.3390/jcm12041412

BibTeX
@article{Katz2023,
  author = {Katz, Moshe and Meitus, Amit and Arad, Michael and Aizer, Anthony and Nof, Eyal and Beinart, Roy},
  title = {Long-Term Outcomes of Tachycardia-Induced Cardiomyopathy Compared with Idiopathic Dilated Cardiomyopathy},
  journal = {Journal of Clinical Medicine},
  year = {2023},
  volume = {12},
  number = {4},
  pages = {1412},
  doi = {10.3390/jcm12041412}
}
Kostenlos starten →